Preliminary experiments suggest conolidine could inhibit distinct ion channels, cutting down neuronal excitability and limiting ache signals. This system is particularly appropriate in neuropathic suffering, wherever abnormal signaling brings about persistent soreness. In addition, conolidine appears to influence G protein-coupled receptor (GPCR) p